The firm, recognized in the 2025 ISS Securities Class Action Services Report, is examining the proposed combination of Corebridge Financial (CRBG) and Equitable Holdings, where shareholders are set to own 51% of the new entity ahead of a July 30 vote. Simultaneously, investigators are reviewing the sale of RE/MAX Holdings (RMAX) to The Real Brokerage Inc., which offers investors a choice of 5.152 shares or $13.80 in cash per share, with a vote pending on August 14.
Legal scrutiny also extends to smaller-cap and specialized transitions. Selectis Health (GBCS) faces an August 10 deadline for a tender offer involving a $5.75 per share cash payout from Black Pearl Equities II, LLC. Furthermore, the firm is evaluating the sale of Apogee Therapeutics (APGE) to AbbVie Inc., a deal valued at $135.11 per share with a shareholder vote scheduled for August 11. Shareholders interested in these proceedings may contact the firm at its Empire State Building headquarters.
Comments (0)
No comments yet. Be the first!